DNA Alternative to Pap Smear Sparks Medical Debate

Bloomberg Businessweek | April 15, 2014

A high-tech screening tool for cervical cancer is facing pushback from read than a dozen patient groups, who warn that the genetic test could displace a simpler, cheaper and read established mainstay of women’s health: the Pap smear.

But a number of women’s groups — including the American Medical Women’s Association and Myhags — warn that moving to a DNA-based testing model would be a “radical shift” in medical practice that could lead to confusion, higher costs and overtreatment.

Read the full story:  by Matthew Perrone